KP Tissue Inc.
DE ˙ DB ˙ CA48265Y1043 ˙ Personal Products
6,85 € ↑0,05 (0,74%)
2021-08-18
AKTIENPREIS
SecurityDE:KP8 / KP Tissue Inc.
InstitutionDFA INVESTMENT TRUST CO - The Canadian Small Company Series
Latest Disclosed Ownership39,800 shares
Latest Disclosed Value $ 333,436
DFA INVESTMENT TRUST CO - The Canadian Small Company Series ownership in KP8 / KP Tissue Inc.

On June 24, 2026 - DFA INVESTMENT TRUST CO - The Canadian Small Company Series filed a NPORT-P form disclosing ownership of 39,800 shares of KP Tissue Inc. (DE:KP8) valued at $333,436 USD as of April 30, 2026. The entity filed a previous NPORT-P on March 27, 2026 disclosing 39,800 shares of KP Tissue Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $272,630 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-06-24 2026-04-30 NP KP Tissue EC CA48265Y1043 39,800 0 0.00 333 12.88 0.0143
2026-03-27 2026-01-31 NP KP Tissue EC CA48265Y1043 39,800 0 0.00 295 10.49 0.0136
2025-12-22 2025-10-31 NP KP Tissue EC CA48265Y1043 39,800 -7,400 -15.68 268 -12.46 0.0140
2025-09-25 2025-07-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 306 11.72 0.0191
2025-06-26 2025-04-30 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 274 5.41 0.0213
2025-03-26 2025-01-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 259 -6.50 0.0200
2024-12-23 2024-10-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 278 -3.82 0.0200
2024-09-26 2024-07-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 288 2.49 0.0200
2024-06-25 2024-04-30 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 282 -9.35 0.0209
2024-03-28 2024-01-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 311 -3.43 0.0245
2023-12-20 2023-10-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 321 -13.48 0.0273
2023-09-29 2023-07-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 372 4.80 0.0270
2023-06-23 2023-04-30 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 354 -1.94 0.0274
2023-03-27 2023-01-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 361 2.85 0.0269
2022-12-28 2022-10-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 351 -8.59 0.0289
2022-09-28 2022-07-31 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 384 -6.34 0.0295
2022-06-28 2022-04-30 NP KP Tissue EC CA48265Y1043 47,200 0 0.00 410 4.59 0.0306
2022-03-29 2022-01-31 NP KP Tissue EC CA48265Y1043 47,200 1,500 3.28 392 -0.76 0.0285
2021-12-09 2021-10-31 NP KP Tissue EC CA48265Y1043 45,700 0 0.00 395 3.40 0.0272
2021-09-24 2021-07-31 NP KP Tissue EC CA48265Y1043 45,700 0 0.00 382 1.87 0.0297
2021-06-15 2021-04-30 NP KP Tissue EC CA48265Y1043 45,700 0 0.00 376 1.90 0.0258
2021-03-25 2021-01-31 NP KP Tissue EC CA48265Y1043 45,700 0 0.00 369 -7.77 0.0306
2020-12-17 2020-10-31 NP KP Tissue EC CA48265Y1043 45,700 0 0.00 399 0.25 0.0411
2020-09-29 2020-07-31 NP KP Tissue EC CA48265Y1043 45,700 1,900 4.34 399 27.56 0.0403
2020-06-18 2020-04-30 NP KP Tissue EC CA48265Y1043 43,800 10,000 29.59 313 15.56 0.0378
2020-03-31 2020-01-31 NP KP Tissue EC CA48265Y1043 33,800 0 0.00 271 22.73 0.0225
2019-12-20 2019-10-31 NP KP Tissue EC CA48265Y1043 33,800 33,800 220 0.0192
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.